Biportal endoscopic versus microscopic discectomy for lumbar herniated disc: a randomized controlled trial

医学 Oswestry残疾指数 随机对照试验 可视模拟标度 神经根痛 物理疗法 腰椎 外科 不利影响 生活质量(医疗保健) 腰痛 背痛 置信区间 内科学 替代医学 护理部 病理
作者
Sang-Min Park,Ho-Jin Lee,Hyunjin Park,Jun-Young Choi,Ohsang Kwon,Sanghoon Lee,Ho-Joong Kim,Jin Sup Yeom
出处
期刊:The Spine Journal [Elsevier]
卷期号:23 (1): 18-26 被引量:16
标识
DOI:10.1016/j.spinee.2022.09.003
摘要

Biportal endoscopic discectomy has been frequently performed in recent years and has shown acceptable clinical outcomes. However, evidence regarding its efficacy and safety remains limited.This study aimed to compare the clinical efficacy and safety of biportal endoscopic with that of open microscopic discectomy in patients with single-level herniated lumbar discs.Prospective, randomized, multicenter, open-label, assessor-blind, non-inferiority controlled trial.Sixty-four participants suffering from low back and leg pain with a single-level herniated lumbar disc and required discectomy.Outcomes were assessed with the use of patient-reported outcome measures (PROMs), visual analog scale (VAS) pain score for surgical site, low back and lower extremity, Oswestry Disability Index (ODI) for lumbar disabilities, European Quality of Life-5 Dimensions value for quality of life, and painDETECT for neuropathic pain. Surgery-related outcomes such as hospital stay, operation time, and opioid usage were collected. Adverse events occurring during the follow-up period were also noted.All participants were randomly assigned in a 1:1 ratio to undergo biportal endoscopic (biportal group) or microscopic discectomy (microscopy group). The primary outcome was the difference in ODI scores at 12-months post surgically based on a modified intention-to-treat strategy, with a non-inferiority margin of 12.8 points. The secondary outcomes included PROMs, surgery-related outcomes, and adverse events.The ODI score at the 12-month follow-up was 11.97 in the microscopy group and 13.89 in the biportal group (mean difference, 1.92; 95% confidence interval [CI], -3.50 to 7.34), showing the non-inferiority of biportal group. The results for the secondary outcomes were similar to those for the primary outcome. Creatinine phosphokinase ratios were low in the biportal group. Early surgical site pain was slightly lower in the biportal group (mean difference of VAS pain score at 48-hr, -0.98; 95% CI, -1.77 to -0.19). Adverse events including reoperation showed no significant difference between the groups.Biportal endoscopic discectomy was non-inferior to microscopic discectomy over a 12 month period. Biportal endoscopic discectomy is suggested to be a relatively safe and effective surgical technique with the slight advantage of reduced muscle damage. However, the clinical implications of surgical site pain should be carefully considered.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
SciGPT应助lxl98采纳,获得10
1秒前
2秒前
罗博超完成签到,获得积分10
2秒前
2秒前
深情丸子发布了新的文献求助10
4秒前
kiwi发布了新的文献求助10
4秒前
爆米花应助515采纳,获得10
5秒前
5秒前
6秒前
zzz4743应助Hdxbfhu采纳,获得50
6秒前
6秒前
8秒前
8秒前
钟吾敷发布了新的文献求助10
9秒前
Orange应助lxl98采纳,获得10
9秒前
99完成签到,获得积分10
10秒前
12秒前
wang发布了新的文献求助10
12秒前
懵懂的曼寒完成签到,获得积分10
13秒前
13秒前
nenoaowu发布了新的文献求助10
13秒前
田様应助深情丸子采纳,获得10
13秒前
14秒前
钟吾敷完成签到,获得积分20
15秒前
小猫咪完成签到,获得积分10
15秒前
16秒前
等待霸发布了新的文献求助10
16秒前
肉球完成签到 ,获得积分10
16秒前
17秒前
xingyu完成签到,获得积分10
17秒前
sumingwong完成签到,获得积分10
18秒前
蒲公英发布了新的文献求助10
20秒前
852应助易一采纳,获得10
20秒前
21秒前
21秒前
22秒前
等待霸完成签到,获得积分10
23秒前
lxl98发布了新的文献求助10
27秒前
木禾发布了新的文献求助10
27秒前
29秒前
高分求助中
【本贴是提醒信息,请勿应助】请在求助之前详细阅读求助说明!!!! 20000
One Man Talking: Selected Essays of Shao Xunmei, 1929–1939 1000
The Three Stars Each: The Astrolabes and Related Texts 900
Yuwu Song, Biographical Dictionary of the People's Republic of China 800
Multifunctional Agriculture, A New Paradigm for European Agriculture and Rural Development 600
Challenges, Strategies, and Resiliency in Disaster and Risk Management 500
Bernd Ziesemer - Maos deutscher Topagent: Wie China die Bundesrepublik eroberte 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 有机化学 工程类 生物化学 纳米技术 物理 内科学 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 电极 光电子学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 2481540
求助须知:如何正确求助?哪些是违规求助? 2144263
关于积分的说明 5468997
捐赠科研通 1866744
什么是DOI,文献DOI怎么找? 927751
版权声明 563039
科研通“疑难数据库(出版商)”最低求助积分说明 496402